搜尋結果
Biden Says Marijuana Being Reclassified As Schedule III Drug
Forbes· 6 日前The Department of Justice moved to reclassify marijuana as a less dangerous drug Thursday, in a ...
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
CNBC· 19 小時前A patient injects herself with an insulin pen. The rivalry between Eli Lilly and Novo Nordisk ...
Why Lilly And Novo Nordisk Will Keep Dominating The Market For Blockbuster GLP-1 Drugs
Forbes· 7 日前... released by KFF this week found that one in eight adults said they’ve taken a GLP-1 drug, ...
FDA approves Amgen's treatment for most deadly form of lung cancer
CNBC· 6 日前The Food and Drug Administration on Thursday approved Amgen's therapy for patients with the ...
AstraZeneca targets $80 billion in total revenue by 2030 in 'post-Covid era'
CNBC· 1 日前The Astrazeneca logo is pictured at the World Artificial Intelligence Conference 2021 in ...
Australia to Ban Copycats of Ozempic Weight Loss Medication
Bloomberg· 13 小時前Australia will ban pharmacies from creating replicas of popular weight loss drugs like Ozempic, ...
Opinion | Swift drug approvals the right medicine for Hong Kong
South China Morning Post· 14 小時前Pharmaceutical firms may submit applications to the Hospital Authority directly without going through doctors under the ...
Amgen Drug Wins US Approval for Advanced Small Cell Lung Cancer
Bloomberg· 6 日前Amgen Inc. won US approval for a new drug to treat a particularly aggressive form of advanced ...
JPMorgan says there's a new GLP-1 drug player and its shares can rally 80%
CNBC· 21 小時前Analyst Hardik Parikh initiated research coverage on the clinical stage drug developer with an ...
Council Post: Medicare Part D In 2024: A Costly Prescription For Retirees?
Forbes· 5 日前Robert Bache (aka "Medicare Bob") is VP of Health at AmeriLife, and Founder of Senior ...